BMC Clinical Pharmacology

Table 5 Significant Correlations of Phase 1, 9^th dose Urinary Metal Excretion with Phase 1, 9^th dose Urinary Metal Excretion (only correlations >0.31 in magnitude are listed, corresponding to p = 0.01 on an individual comparison basis)

From: Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A - Medical results

Metal	Correlations
Pb	Tl(0.47), Sb(0.35), Al (0.56)
Sn	none
Hg	none
Tl	Pb(0.47)
Sb	Pb(0.35), Cd(0.67), Al (0.63)
W	None
Al	Pb (0.56), Sb (0.63), Cd (0.67)
Cd	Sb (0.67), Al (0.67)
As	Pb (0.56), Sb (0.63), Cd (0.67)

Back to article page